Osteocalcin-expressing neutrophils from skull bone marrow exert immunosuppressive and neuroprotective effects after TBI

Cell Rep. 2024 Sep 24;43(9):114670. doi: 10.1016/j.celrep.2024.114670. Epub 2024 Aug 30.

Abstract

Neutrophils from skull bone marrow (Nskull) are activated under some brain stresses, but their effects on traumatic brain injury (TBI) are lacking. Here, we find Nskull infiltrates brain tissue quickly and persistently after TBI, which is distinguished by highly and specifically expressed osteocalcin (OCN) from blood-derived neutrophils (Nblood). Reprogramming of glucose metabolism by reducing glycolysis-related enzyme glyceraldehyde 3-phosphate dehydrogenase expression is involved in the antiapoptotic and proliferative abilities of OCN-expressing Nskull. The transcription factor Fos-like 1 governs the specific gene profile of Nskull including C-C motif chemokine receptor-like 2 (CCRL2), arginase 1 (Arg1), and brain-derived neurotrophic factor (BDNF) in addition to OCN. Selective knockout of CCRL2 in Nskull demonstrates that CCRL2 mediates its recruitment, whereas high Arg1 expression is consistent with its immunosuppressive effects on Nblood, and the secretion of BDNF facilitating dendritic growth contributes to its neuroprotection. Thus, our findings provide insight into the roles of Nskull in TBI.

Keywords: CP: Immunology; CP: Neuroscience; immunosuppression; neuroprotection; neutrophil; skull bone marrow; traumatic brain injury.

MeSH terms

  • Animals
  • Arginase / metabolism
  • Bone Marrow / metabolism
  • Brain Injuries, Traumatic* / metabolism
  • Brain Injuries, Traumatic* / pathology
  • Brain-Derived Neurotrophic Factor / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neuroprotection
  • Neuroprotective Agents / pharmacology
  • Neutrophils* / metabolism
  • Osteocalcin* / metabolism
  • Skull / metabolism
  • Skull / pathology

Substances

  • Osteocalcin
  • Arginase
  • Brain-Derived Neurotrophic Factor
  • Neuroprotective Agents